Literature DB >> 21298369

Neural mechanisms of angiotensin II-salt hypertension: implications for therapies targeting neural control of the splanchnic circulation.

John W Osborn1, Gregory D Fink, Marcos T Kuroki.   

Abstract

Chronically elevated plasma angiotensin II (AngII) causes a salt-sensitive form of hypertension that is associated with a differential pattern of peripheral sympathetic outflow. This "AngII-salt sympathetic signature" is characterized by a transient reduction in sympathetic nervous system activity (SNA) to the kidneys, no change in SNA to skeletal muscle, and a delayed activation of SNA to the splanchnic circulation. Studies suggest that the augmented sympathetic influence on the splanchnic vascular bed increases vascular resistance and decreases vascular capacitance, leading to hypertension via translocation of blood volume from the venous to the arterial circulation. This unique sympathetic signature is hypothesized to be generated by a balance of central excitatory inputs and differential baroreceptor inhibitory inputs to sympathetic premotor neurons in the rostral ventrolateral medulla. The relevance of these findings to human hypertension and the future development of targeted sympatholytic therapies are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21298369      PMCID: PMC3076522          DOI: 10.1007/s11906-011-0188-9

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  46 in total

1.  Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension.

Authors:  L Gabriel Navar
Journal:  J Appl Physiol (1985)       Date:  2010-12

2.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Authors:  Murray D Esler; Henry Krum; Paul A Sobotka; Markus P Schlaich; Roland E Schmieder; Michael Böhm
Journal:  Lancet       Date:  2010-11-17       Impact factor: 79.321

Review 3.  Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept.

Authors:  Markus P Schlaich; Paul A Sobotka; Henry Krum; Robert Whitbourn; Anthony Walton; Murray D Esler
Journal:  Hypertension       Date:  2009-10-12       Impact factor: 10.190

4.  Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.

Authors:  Murray Esler; Elisabeth Lambert; Markus Schlaich
Journal:  J Appl Physiol (1985)       Date:  2010-02-25

5.  Effects of central sodium on epithelial sodium channels in rat brain.

Authors:  Hong-Wei Wang; Md Shahrier Amin; Esraa El-Shahat; Bing S Huang; Balwant S Tuana; Frans H H Leenen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-04-28       Impact factor: 3.619

Review 6.  The sympathetic system and hypertension.

Authors:  M Esler
Journal:  Am J Hypertens       Date:  2000-06       Impact factor: 2.689

Review 7.  Sympathetic nervous system and the kidney in hypertension.

Authors:  Gerald F DiBona
Journal:  Curr Opin Nephrol Hypertens       Date:  2002-03       Impact factor: 2.894

8.  Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors.

Authors:  János Peti-Peterdi; David G Warnock; P Darwin Bell
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

Review 9.  Region-specific changes in sympathetic nerve activity in angiotensin II-salt hypertension in the rat.

Authors:  John W Osborn; Gregory D Fink
Journal:  Exp Physiol       Date:  2009-08-28       Impact factor: 2.969

10.  Splanchnic circulation is a critical neural target in angiotensin II salt hypertension in rats.

Authors:  Andrew J King; John W Osborn; Gregory D Fink
Journal:  Hypertension       Date:  2007-07-23       Impact factor: 10.190

View more
  46 in total

Review 1.  The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.

Authors:  John W Wright; Joseph W Harding
Journal:  Pflugers Arch       Date:  2012-04-26       Impact factor: 3.657

2.  (In)activity-dependent alterations in resting and reflex control of splanchnic sympathetic nerve activity.

Authors:  Nicholas A Mischel; Patrick J Mueller
Journal:  J Appl Physiol (1985)       Date:  2011-10-06

3.  Sympathetic signatures of cardiovascular disease: a blueprint for development of targeted sympathetic ablation therapies.

Authors:  John W Osborn; Marcos T Kuroki
Journal:  Hypertension       Date:  2012-02-06       Impact factor: 10.190

Review 4.  Recording sympathetic nerve activity chronically in rats: surgery techniques, assessment of nerve activity, and quantification.

Authors:  Sean D Stocker; Martin S Muntzel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-06       Impact factor: 4.733

5.  A new conceptual paradigm for the haemodynamics of salt-sensitive hypertension: a mathematical modelling approach.

Authors:  Viktoria A Averina; Hans G Othmer; Gregory D Fink; John W Osborn
Journal:  J Physiol       Date:  2012-08-13       Impact factor: 5.182

Review 6.  Pivotal role of α2 Na+ pumps and their high affinity ouabain binding site in cardiovascular health and disease.

Authors:  Mordecai P Blaustein; Ling Chen; John M Hamlyn; Frans H H Leenen; Jerry B Lingrel; W Gil Wier; Jin Zhang
Journal:  J Physiol       Date:  2016-07-31       Impact factor: 5.182

7.  Discharge of RVLM vasomotor neurons is not increased in anesthetized angiotensin II-salt hypertensive rats.

Authors:  Gustavo R Pedrino; Alfredo S Calderon; Mary Ann Andrade; Sergio L Cravo; Glenn M Toney
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-11       Impact factor: 4.733

Review 8.  Report of the National Heart, Lung, and Blood Institute Working Group on Hypertension: Barriers to Translation.

Authors:  Curt D Sigmund; Robert M Carey; Lawrence J Appel; Donna K Arnett; Hayden B Bosworth; William C Cushman; Zorina S Galis; Melissa Green Parker; John E Hall; David G Harrison; Alicia A McDonough; Holly L Nicastro; Suzanne Oparil; John W Osborn; Mohan K Raizada; Jacqueline D Wright; Young S Oh
Journal:  Hypertension       Date:  2020-02-17       Impact factor: 10.190

Review 9.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

10.  Synapses, signals, CDs, and cytokines: interactions of the autonomic nervous system and immunity in hypertension.

Authors:  Meena S Madhur; David G Harrison
Journal:  Circ Res       Date:  2012-10-12       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.